Interval cancer audit and disclosure in cervical screening programmes: An international survey. (June 2022)

• Record Type: Journal Article
• Authors: Fitzpatrick, Patricia; Mooney, Therese; Byrne, Helen; Healy, Orla; Russell, Noirin; O'Reilly, Susan
• Is Part Of: Journal of medical screening. Volume 29:Number 2(2022)
• Page Start: 104
• Page End: 109
• Publication Date: 2022-06
• Subjects: Cervix -- interval cancer -- screening; Medical screening -- Periodicals; 362.177
• DOI: 10.1177/09691413211062344
• Languages: English
• ISSNs: 0969-1413

Abstract

Background: Legal cases involving the National Cervical Screening Programme in Ireland following non-disclosure of an interval cervical cancer audit prompted this first international comparative survey of interval cervical cancer audit. Methods: A survey of 22 international population-based cervical screening programmes was conducted, to determine if they undertook audit of invasive cervical cancers. Those countries/regions that perform reviews were asked (i) how the audit was undertaken, including how the reviews were performed and how they controlled for retrospective bias, (ii) how women are informed of the audit process and how their consent is obtained, and (iii) how audit results were disclosed to patients. Results: Seventeen countries/regions invited completed the survey (77%); 65% (11/17) have an audit process for interval cervical cancers. Five perform individual patient reviews; three perform programme-wide review, with calculation of interval cancer detection rates; one routinely performs programme-wide review with calculation of interval cancer detection rates and offers individual reviews, and one routinely performs local hospital-level reviews. In the remaining country/region, hospital laboratories audit cancers, with a national audit process for all cervical cancers. Varying methodologies for retrospective cytology review were employed; four include control samples, with a ratio varying from 1:1 to 1:2. Three conduct a blinded review. Most countries/regions do not discuss interval cancer audit with participants and 3/11 (27.3%) inform women when a cervical cancer audit takes place. Disclosure is limited and variable. Conclusion: The responses suggest that there is no consistent approach to audit of interval cervical cancers or to disclosure of audit results.